Armenia vs Venezuela: The number of people with susceptibility test result for rifampicin
Armenia
209
in 2021
Venezuela
198
in 2021
Armenia rank
93rd
Venezuela rank
94th
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Venezuela
How they compare
Armenia currently reports 209 against 198 in Venezuela, a difference of 11.
That makes Armenia's figure about 1.1 times Venezuela's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Venezuela ahead.
Armenia ranks 93rd and Venezuela ranks 94th of 155 countries.
Across the 2 decades both report, Armenia averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Armenia | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 267.67 | 383 | 115.33 | Venezuela |
| 2020s | 203.5 | 152.5 | 51 | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Venezuela?
- Armenia, at 209 against 198 in Venezuela as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Venezuela?
- 11, with Armenia ahead.
- How many years of comparable data are there for Armenia and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 93rd and Venezuela ranks 94th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.